What are the causes of hyponatremia, hyperkalemia, hypovolemia, and high anion‑gap metabolic acidosis with normal glucose in infants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Hyponatremia, Hyperkalemia, Hypovolemia, and High Anion-Gap Metabolic Acidosis in Infants

In infants presenting with this constellation of findings (hyponatremia, hyperkalemia, hypovolemia, and high anion-gap metabolic acidosis with normal glucose), the primary causes are congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency and secondary pseudohypoaldosteronism (PHA) associated with urinary tract infections, with CAH being the most common inherited cause and secondary PHA being a critical transient condition to recognize.

Primary Differential Diagnosis

Aldosterone Deficiency States (Primary Hypoaldosteronism)

The most common cause in this clinical scenario is congenital adrenal hyperplasia due to 21-hydroxylase deficiency, which accounts for approximately 84% (32/38) of primary hypoaldosteronism cases presenting with hyperkalemia in young children 1. This represents the most common inherited disorder of aldosterone synthesis and presents with life-threatening electrolyte disturbances in the first weeks of life 2.

Additional primary hypoaldosteronism causes include:

  • Isolated hypoaldosteronism from CYP11B2 gene mutations 1
  • Xp21 contiguous gene deletion syndrome 1
  • Primary adrenal insufficiency from other etiologies 1

Aldosterone Resistance (Pseudohypoaldosteronism)

Secondary pseudohypoaldosteronism associated with urinary tract infections is a critical transient renal tubular dysfunction that occurs specifically in infants with infectious renal parenchymal involvement 3, 4. This condition presents with:

  • Hyponatremia
  • Hyperkalemia
  • Metabolic acidosis
  • Markedly elevated serum renin AND aldosterone levels (distinguishing it from primary hypoaldosteronism) 4
  • Renal tubular unresponsiveness to aldosterone 3

This is particularly important because it can present with life-threatening shock and respiratory failure requiring mechanical ventilation 4, yet it is completely reversible with treatment of the underlying infection.

Primary PHA types include:

  • PHA type 1 (NR3C2 gene mutations) 1
  • PHA type 2 (CUL3 or KLHL3 gene mutations) 1
  • PHA type 3 (secondary to urinary or intestinal tract pathologies) 1

High Anion-Gap Metabolic Acidosis Contributors

While the hyperkalemia and hyponatremia point toward aldosterone defects, the high anion-gap component requires additional consideration:

In the context of severe dehydration from gastroenteritis (which can coexist), high anion-gap acidosis results from:

  • Elevated lactate (mean 3.4 ± 0.7 mmol/L) 5
  • Elevated phosphate (mean 2.3 ± 0.2 mmol/L) 5
  • Elevated total protein from hemoconcentration 5
  • Elevated creatinine from prerenal azotemia 5

This contrasts with hyperchloremic normal anion-gap acidosis seen in simple diarrheal losses 5.

Diagnostic Algorithm

Step 1: Measure plasma aldosterone and renin levels

  • Elevated aldosterone + elevated renin = Aldosterone resistance (PHA) 4
  • Low aldosterone + elevated renin = Primary hypoaldosteronism (CAH most likely) 1

Step 2: If aldosterone resistance suspected, evaluate for UTI

  • Urine culture and sensitivity 4
  • Renal ultrasound to assess for vesicoureteral reflux or obstructive uropathy 2

Step 3: If primary hypoaldosteronism suspected

  • 17-hydroxyprogesterone level (elevated in 21-hydroxylase deficiency)
  • ACTH stimulation test
  • Molecular genetic analysis for definitive diagnosis 1

Step 4: Assess anion gap contributors

  • Lactate level
  • Creatinine and BUN
  • Phosphate level
  • Consider organic acid screening if anion gap remains unexplained 6

Critical Management Pitfall

A normal plasma aldosterone level does NOT rule out an aldosterone defect in either biosynthesis or function, especially in young infants 1. This is a crucial caveat that can lead to missed diagnoses if clinicians rely solely on aldosterone levels for screening.

Treatment Implications

For secondary PHA associated with UTI, isotonic solutions (0.9% saline or lactated Ringer's) correct not only the volume depletion but also the hyperkalemia and acidosis 3. This is because correcting the volume status and treating the infection resolves the renal tubular unresponsiveness to aldosterone, making this a completely reversible condition.

For primary hypoaldosteronism (CAH), lifelong mineralocorticoid and glucocorticoid replacement is required, with acute management including volume resuscitation and correction of life-threatening hyperkalemia.

Related Questions

What are the differential diagnoses for a patient presenting with hyponatremia, hyperkalemia, hypovolemia, a high anion‑gap metabolic acidosis, and normal glucose?
What is the appropriate initial management for a patient with tachycardia (heart rate 130 bpm) and high‑anion‑gap metabolic acidosis (anion gap 26, potassium 3.0 mmol/L, glucose 173 mg/dL) based on the provided laboratory values?
In a patient with a serum glucose of 424 mg/dL, an anion gap of 13, arterial pH of 7.49, pCO₂ of 29 mm Hg, and bicarbonate of 21.8 mEq/L, how should the mixed metabolic acidosis and respiratory alkalosis be interpreted and managed?
What are the renal causes of hyponatremia in infants?
In a 2‑week‑old infant presenting with poor feeding, vomiting, lethargy, weight loss, hyponatremia, hyperkalemia, and hypoglycemia, what potentially life‑threatening diagnosis must be considered?
How should I evaluate and manage an adult patient with suspected autosomal dominant polycystic kidney disease?
What is the Folate Receptor Autoantibody Test (FRAT)?
Is cefpodoxime 200–400 mg twice daily for 10 days safe in elderly patients, and what dosing adjustments are required based on renal function?
What is the efficacy and safety rating of fosfomycin for treating uncomplicated urinary tract infection in elderly patients?
What are the brand names for methadone (generic)?
In a patient whose chest CT performed one year ago was normal, what is the next appropriate imaging or work‑up to evaluate for a possible newly developing malignancy causing aggressive osteoarthritis‑like changes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.